NeedleSmart, which is based in Liverpool and has offices in Philadelphia, is market-leading hardware and software solution, offering the world's first end-to-end safe needle destruction technology.
All NeedleSmart hardware can sterilise the destroyed needle, directly reducing needlestick injuries (NSI) while dramatically reducing disposal costs and carbon emissions associated with the disposal process.
The flagship product – NeedleSmart Pro, can destroy a contaminated hypodermic needle in a sealed chamber in six seconds, minimising post-procedural NSI. It heats the needle to 2372 degrees Fahrenheit, killing potentially harmful pathogens, viruses and bacteria adhering to the needle. In seconds, the needle is compressed into a tiny ball and released from the NeedleSmart device as a safe sphere of metal at the tip of the syringe.
NeedleSmart have recently achieved FDA approval as a Class II medical device.  The device is now being used in NHS trusts across the UK as part of the nationwide pilot, where its focus is shared between safety enhancement, carbon reduction and sustainability.
The NeedleSmart software pairs with the NeedleSmart hardware gathering in real-time critical “injection event” information, while offering significant time, a reduction in clinical burnout,  and offers significant improvements in data hygiene, and recordation capability.